Search research articles
Contact Us
Filters
Showing results (191-200 of 216) with videos related to
Page
of 22
Sort By:
Journal of Cancer
|
April 30, 2025
Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma
Sachin Kumar, Chung-Che Wu, Fitria Sari Wulandari, et al.
British Journal of Cancer
|
March 6, 2024
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data
Shehara Mendis, Lara Lipton, Yat Hang To, et al.
European Journal of Clinical Pharmacology
|
September 4, 2021
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites
Zheng Liu, Jennifer H Martin, Winston Liauw, et al.
BMC Public Health
|
August 26, 2025
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population
Emma Sanderson, Belinda Lee, Nadia Ayres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, et al.
JAMA Oncology
|
July 3, 2025
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial
Bo Gao, Matteo S Carlino, Michael Michael, et al.
Heliyon
|
January 15, 2025
A non-randomised open-label exploratory 'window of opportunity' study of TG02 treatment in patients with locally advanced primary and recurrent <i>RAS</i> mutant colorectal cancer
Sara Roth, Kasmira Claire Wilson, Robert George Ramsay, et al.
Neuroendocrinology
|
September 1, 2022
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy
Minmin Li, David L Chan, Gonzalo Tapia Rico, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum
Jennifer A Westwood, William K Murray, Melanie Trivett, et al.
The New England Journal of Medicine
|
September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Trevor Leong, B Mark Smithers, Michael Michael, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 216) with videos related to
Sort By:
Page
of 22
Journal of Cancer
|
April 30, 2025
Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma
Sachin Kumar, Chung-Che Wu, Fitria Sari Wulandari, et al.
British Journal of Cancer
|
March 6, 2024
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data
Shehara Mendis, Lara Lipton, Yat Hang To, et al.
European Journal of Clinical Pharmacology
|
September 4, 2021
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites
Zheng Liu, Jennifer H Martin, Winston Liauw, et al.
BMC Public Health
|
August 26, 2025
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population
Emma Sanderson, Belinda Lee, Nadia Ayres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, et al.
JAMA Oncology
|
July 3, 2025
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial
Bo Gao, Matteo S Carlino, Michael Michael, et al.
Heliyon
|
January 15, 2025
A non-randomised open-label exploratory 'window of opportunity' study of TG02 treatment in patients with locally advanced primary and recurrent <i>RAS</i> mutant colorectal cancer
Sara Roth, Kasmira Claire Wilson, Robert George Ramsay, et al.
Neuroendocrinology
|
September 1, 2022
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy
Minmin Li, David L Chan, Gonzalo Tapia Rico, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum
Jennifer A Westwood, William K Murray, Melanie Trivett, et al.
The New England Journal of Medicine
|
September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Trevor Leong, B Mark Smithers, Michael Michael, et al.
Page
of 22